Abstract Purpose of Review This paper reviews treatment options for sleep disordered
breathing (SDB) in patients with heart failure. We sought to identify therapies for SDB with …

It is increasingly recognized that sleep-disordered breathing (SDB) is a common modifiable
risk factor for cardiovascular disease with significant impact on morbidity and potentially …

Heart failure is a growing problem, placing an increasing burden on public health resources
and continuing to exert a high toll in mortality and morbidity. Sleep disordered breathing …

Opinion statement Sleep disordered breathing (SDB) is common in heart failure patients
across the range of ejection fractions and is associated with adverse prognosis. Although …

Sleep-disordered breathing (SDB) is the most common comorbidity in patients with heart
failure (HF) and has a significant impact on quality of life, morbidity, and mortality. A number …

Findings from recent literature suggest that improved screening, diagnosis, and innovative
treatment of SDB in heart failure patients can reduce morbidity, mortality, and healthcare …

The prevalence of sleep-disordered breathing (SDB) in the general population is 2% to 4%,
1 in contrast SDB is much more common in patients with heart failure (HF), with the …

Sleep disordered breathing (SDB) is a common co-morbidity in patients with heart failure
(HF). Both its forms—central and obstructive sleep apnea—are highly prevalent in this …

In patients with congestive heart failure, sleep disordered breathing occurs commonly and is
associated with an increased mortality. In addition to central sleep apnea (Cheyne–Stokes …

Abstract Sleep-disordered breathing (SDB), either obstructive sleep apnoea (OSA) or central
sleep apnoea (CSA)/Cheyne-Stokes respiration (CSR) and often a combination of the two, is …